T. Gulliford

582 citations
10 papers · 456 indexed · h-index 8
Topics
HER2/EGFR in Cancer Research (4 papers)Drug Transport and Resistance Mechanisms (2 papers)Monoclonal and Polyclonal Antibodies Research (2 papers)

In The Last Decade

T. Gulliford

10 papers receiving 443 citations

Peers

T. Gulliford
Comparison fields: 5 of 75
  • Oncology 230
  • Molecular Biology 134
  • Pathology and Forensic Medicine 130
  • Cancer Research 96
  • Genetics 68
Replace Sylvain L’Espérance with:
Sylvain L’Espérance Canada
Reinaldo Chacón Argentina
Matilde Pensabene Italy
Amy Dresen United States
SR Ebbs United Kingdom
D. P. Ryan United States
Patel Dd India
Ioana Kloos France
Vittoria Stigliano Italy
Brian Pruitt United States
T. Gulliford relative to Sylvain L’Espérance Canada Sylvain L’Espérance's profile →
Citations per field
00.5×1.5×1.9×
Sylvain L’Espérance · 1×
Citations per year

Countries citing papers authored by T. Gulliford

Since Specialization
Citations

This map shows the geographic impact of T. Gulliford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Gulliford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Gulliford more than expected).

Fields of papers citing papers by T. Gulliford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Gulliford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Gulliford. The network helps show where T. Gulliford may publish in the future.

Co-authorship network of co-authors of T. Gulliford

This figure shows the co-authorship network connecting the top 25 collaborators of T. Gulliford. A scholar is included among the top collaborators of T. Gulliford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Gulliford. T. Gulliford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 33
2 112
3
Chemosensitization of solid tumor cells by alteration of their susceptibility to apoptosis.
13
4
Chemosensitization of solid tumors by modulation of resistance mechanisms.
15
5 1
6 13
7 127
8 113
9 22
10 7

About T. Gulliford

T. Gulliford is a scholar working on Oncology, Pharmaceutical Science and Cancer Research, having authored 10 papers that have together received 456 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (230 citations), Pathology and Forensic Medicine (130 citations) and Cancer Research (96 citations). T. Gulliford has collaborated with scholars based in United Kingdom, Switzerland and Denmark. Frequent co-authors include Richard J. Epstein, Emily Wilson, I. W. F. Hanham, R. Charles Coombes, J English, Sebastian Möller, K W Colston, Ian A. Cree, Louise A. Knight and Federica Di Nicolantonio. Their work appears in journals such as Journal of Biological Chemistry, British Journal of Cancer and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026